#VisualAbstract by @md_abdulqader83
www.kireports.org/ar...
@lobbedezt.bsky.social @clemencebechade.bsky.social
#VisualAbstract by @md_abdulqader83
www.kireports.org/ar...
@lobbedezt.bsky.social @clemencebechade.bsky.social
#VisualAbstract by @md_abdulqader83
www.kireports.org/ar...
@lobbedezt.bsky.social @clemencebechade.bsky.social
https://buff.ly/3DbBiJm
https://buff.ly/3DbBiJm
FDA says it has greenlighted temporary imports of a variety of IV products, ranging from Canada to China
www.fda.gov/drugs/update...
FDA says it has greenlighted temporary imports of a variety of IV products, ranging from Canada to China
www.fda.gov/drugs/update...
Of note, 16% of PD pts were using icodextrin, common question as to whether CGMs can be used in this group
https://bit.ly/JASN0693
#ASNJASN
@rajmehrotra.bsky.social
Of note, 16% of PD pts were using icodextrin, common question as to whether CGMs can be used in this group
Optimizing PD with a focus on Incodextrin
🗓️ Feb. 11th
⏰4-5 PM CET
👩⚕️Dagmara Borzych-Duzalka
✏️Register here: https://register.gotowebinar.com/register/8036686072630541914
#ERKNet #Webinar #Rarekidneydisease #MedicalEducation #Icodextrin
Optimizing PD with a focus on Incodextrin
🗓️ Feb. 11th
⏰4-5 PM CET
👩⚕️Dagmara Borzych-Duzalka
✏️Register here: https://register.gotowebinar.com/register/8036686072630541914
#ERKNet #Webinar #Rarekidneydisease #MedicalEducation #Icodextrin
Read “Critical Appraisal of Endpoints and Statistical Strategies in the DIDO trial”
📖 Read here: doi.org/10.1016/j.ek...
Great to see ongoing discussion that helps strengthen future research.
Read “Critical Appraisal of Endpoints and Statistical Strategies in the DIDO trial”
📖 Read here: doi.org/10.1016/j.ek...
Great to see ongoing discussion that helps strengthen future research.
Originally a dietary glucose polymer, it became a CAPD breakthrough after the MIDAS trial & used globally.
An innovation with real impact – & a twist in the tale.
🔗www.ukkidney.org/75-...
Originally a dietary glucose polymer, it became a CAPD breakthrough after the MIDAS trial & used globally.
An innovation with real impact – & a twist in the tale.
🔗www.ukkidney.org/75-...
Genta 😇
Ceftazidime 😇
Ampicillin and amoxicillin 😇
Piperacillin/tazobactam 😇
Meropenem 😇
Imipenem ⚠️
Ciprofloxacin 😇
Vancomycin 😇...
Genta 😇
Ceftazidime 😇
Ampicillin and amoxicillin 😇
Piperacillin/tazobactam 😇
Meropenem 😇
Imipenem ⚠️
Ciprofloxacin 😇
Vancomycin 😇...
doi.org/10.1177/0896...
doi.org/10.1177/0896...